Acrobiosystems (301080.SZ) issued a pre-announcement, expecting a net profit of 120 million to 140 million yuan for the year 2024, a year-on-year decrease of 8.85% to 21.87%.
Beposite (301080.SZ) released its 2024 performance forecast, with the company expecting its 2024 attributable...
Acrobiosystems (301080.SZ) released its performance forecast for the year 2024, with the company expecting a net profit attributable to shareholders of the listed company of 1.2 billion to 1.4 billion yuan, a year-on-year decrease of 8.85% to 21.87%; after deducting non-recurring gains and losses, the net profit is expected to be 1.1 billion to 1.3 billion yuan, a year-on-year decrease of 7.41% to 21.65%.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
